Russell Investments Group Ltd. Lowers Stock Holdings in Mettler-Toledo International, Inc. $MTD

Russell Investments Group Ltd. lessened its stake in Mettler-Toledo International, Inc. (NYSE:MTD) by 1.4% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 106,108 shares of the medical instruments supplier’s stock after selling 1,531 shares during the period. Russell Investments Group Ltd.’s holdings in Mettler-Toledo International were worth $129,834,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. EverSource Wealth Advisors LLC lifted its position in Mettler-Toledo International by 2.4% during the 3rd quarter. EverSource Wealth Advisors LLC now owns 294 shares of the medical instruments supplier’s stock worth $361,000 after acquiring an additional 7 shares during the period. GAMMA Investing LLC increased its holdings in shares of Mettler-Toledo International by 1.6% in the third quarter. GAMMA Investing LLC now owns 510 shares of the medical instruments supplier’s stock valued at $626,000 after purchasing an additional 8 shares during the period. Versant Capital Management Inc increased its holdings in shares of Mettler-Toledo International by 42.1% in the third quarter. Versant Capital Management Inc now owns 27 shares of the medical instruments supplier’s stock valued at $33,000 after purchasing an additional 8 shares during the period. Valeo Financial Advisors LLC raised its stake in shares of Mettler-Toledo International by 4.0% during the third quarter. Valeo Financial Advisors LLC now owns 207 shares of the medical instruments supplier’s stock worth $254,000 after purchasing an additional 8 shares during the last quarter. Finally, Meridian Wealth Management LLC raised its stake in shares of Mettler-Toledo International by 1.7% during the third quarter. Meridian Wealth Management LLC now owns 480 shares of the medical instruments supplier’s stock worth $589,000 after purchasing an additional 8 shares during the last quarter. 95.07% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Mettler-Toledo International

In other Mettler-Toledo International news, CFO Shawn Vadala sold 800 shares of the stock in a transaction on Tuesday, February 10th. The stock was sold at an average price of $1,410.12, for a total transaction of $1,128,096.00. Following the sale, the chief financial officer owned 5,288 shares in the company, valued at approximately $7,456,714.56. This represents a 13.14% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.77% of the company’s stock.

Analysts Set New Price Targets

Several analysts have recently commented on MTD shares. Weiss Ratings restated a “hold (c+)” rating on shares of Mettler-Toledo International in a research note on Monday, December 29th. Citigroup boosted their target price on Mettler-Toledo International from $1,600.00 to $1,700.00 and gave the stock a “buy” rating in a research report on Monday, November 10th. Barclays decreased their price target on Mettler-Toledo International from $1,600.00 to $1,550.00 and set an “overweight” rating on the stock in a research note on Monday, December 15th. Wall Street Zen raised Mettler-Toledo International from a “hold” rating to a “buy” rating in a report on Saturday, February 14th. Finally, The Goldman Sachs Group began coverage on Mettler-Toledo International in a research report on Tuesday, December 9th. They issued a “neutral” rating and a $1,475.00 price objective for the company. Six analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. According to data from MarketBeat.com, Mettler-Toledo International currently has a consensus rating of “Hold” and an average price target of $1,435.42.

Mettler-Toledo International Trading Up 3.4%

Shares of NYSE MTD opened at $1,251.00 on Tuesday. The stock has a market cap of $25.43 billion, a price-to-earnings ratio of 29.70, a PEG ratio of 2.54 and a beta of 1.43. Mettler-Toledo International, Inc. has a 52 week low of $946.69 and a 52 week high of $1,525.17. The company’s 50-day moving average price is $1,394.88 and its 200 day moving average price is $1,371.81.

Mettler-Toledo International (NYSE:MTD) last posted its earnings results on Thursday, February 5th. The medical instruments supplier reported $13.36 earnings per share for the quarter, beating the consensus estimate of $12.76 by $0.60. The firm had revenue of $1.13 billion during the quarter, compared to the consensus estimate of $1.10 billion. Mettler-Toledo International had a net margin of 21.59% and a negative return on equity of 495.07%. The firm’s revenue for the quarter was up 8.1% on a year-over-year basis. During the same period last year, the firm posted $12.41 EPS. Mettler-Toledo International has set its Q1 2026 guidance at 8.600-8.750 EPS and its FY 2026 guidance at 46.050-46.700 EPS. As a group, research analysts expect that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current year.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.